Ranibizumab News and Research

RSS
Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Common medication used to treat diabetic macular edema is less effective in Black patients

Common medication used to treat diabetic macular edema is less effective in Black patients

Drugs used to treat retinal diseases are excreted into human breast milk, study finds

Drugs used to treat retinal diseases are excreted into human breast milk, study finds

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

Easier treatment for age-related macular degeneration shows promise in clinical study

Easier treatment for age-related macular degeneration shows promise in clinical study

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Scientists move one step further in developing eye drops to treat age-related macular degeneration

Study suggests potential means of stalling or even reversing diabetes-related blindness

Study suggests potential means of stalling or even reversing diabetes-related blindness

Largest clinical specialty database powers studies that yield key insights

Largest clinical specialty database powers studies that yield key insights

Scientists identify molecule that could be targeted to prevent vision loss in diabetics and preterm infants

Scientists identify molecule that could be targeted to prevent vision loss in diabetics and preterm infants

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

Added benefit of aflibercept not proven in myopic choroidal neovascularisation

Added benefit of aflibercept not proven in myopic choroidal neovascularisation

New study reveals better treatment options for proliferative diabetic retinopathy

New study reveals better treatment options for proliferative diabetic retinopathy

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

NAM announces election of three new members from UC San Diego School of Medicine

NAM announces election of three new members from UC San Diego School of Medicine

Risk for endophthalmitis no higher with Avastin, finds study

Risk for endophthalmitis no higher with Avastin, finds study

Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients

Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.